Explain Where New Eucrisa Fits Into Eczema Treatment

The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.

Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.

Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote